Impact of Restricted Reimbursement on the Use of Statins in Finland A Register-Based Study




Martikainen JE, Saastamoinen LK, Korhonen MJ, Enlund H, Helin-Salmivaara A

PublisherLIPPINCOTT WILLIAMS & WILKINS

2010

 Medical Care

MEDICAL CARE

MED CARE

9

48

9

761

766

6

0025-7079

DOIhttps://doi.org/10.1097/MLR.0b013e3181e41bcb



Conclusions: Restricted reimbursement of expensive statins decreased their use. It seems that after the policy new statin treatments have channeled appropriately. Although it is likely that the cost-containment aim of the policy was reached, health and long-term effects are not known.



Last updated on 26/11/2024 10:23:37 PM